首页> 外文期刊>Applied Microbiology and Biotechnology >A derivative of the menaquinone precursor 1,4-dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by aerobically grown Shewanella oneidensis MR-1
【24h】

A derivative of the menaquinone precursor 1,4-dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by aerobically grown Shewanella oneidensis MR-1

机译:甲萘醌前体1,4-二羟基-2-萘甲酸酯的衍生物参与需氧生长的印度产希瓦氏菌MR-1对四氯化碳的还原转化

获取原文
获取原文并翻译 | 示例
           

摘要

Transformation of carbon tetrachloride (CT) by Shewanella oneidensis MR-1 has been proposed to involve the anaerobic respiratory-chain component menaquinone. To investigate this hypothesis a series of menaquinone mutants were constructed. The menF mutant is blocked at the start of the menaquinone biosynthetic pathway. The menB, menA and menG mutants are all blocked towards the end of the pathway, being unable to produce 1,4-dihydroxy-2-naphthoic acid (DHNA), demethyl-menaquinone and menaquinone , respectively. Aerobically grown mutants unable to produce the menaquinone precursor DHNA (menF and menB mutants) showed a distinctly different CT transformation profile than mutants able to produce DHNA but unable to produce menaquinone (menA and menG mutants). While DHNA did not reduce CT in an abiotic assay, the addition of DHNA to the menF and menB mutants restored normal CT transformation activity. We conclude that a derivative of DHNA, that is distinct from menaquinone, is involved in the reduction of CT by aerobically grown S. oneidensis MR-1. When cells were grown anaerobically with trimethylamine-N-oxide as the terminal electron acceptor, all the menaquinone mutants showed wild-type levels of CT reduction. We conclude that S. oneidensis MR-1 produces two different factors capable of dehalogenating CT. The factor produced under anaerobic growth conditions is not a product of the menaquinone biosynthetic pathway. [References: 18]
机译:有人提出了由印度产希瓦氏菌(Shewanella oneidensis)MR-1转化四氯化碳(CT)涉及厌氧呼吸链成分甲萘醌。为了研究该假设,构建了一系列甲萘醌突变体。 menF突变体在甲萘醌生物合成途径的开始被阻断。 menB,menA和menG突变体均在通路末端被封闭,无法分别产生1,4-二羟基-2-萘甲酸(DHNA),去甲基甲萘醌和甲萘醌。有氧生长的无法产生甲萘醌前体DHNA的突变体(menF和menB突变体)与能够产生DHNA但不能产生甲萘醌的突变体(menA和menG突变体)表现出截然不同的CT转换曲线。尽管在非生物测定中DHNA不会降低CT,但在menF和menB突变体中添加DHNA可以恢复正常的CT转化活性。我们得出的结论是,DHNA的衍生物与甲萘醌不同,该衍生物与需氧菌S.oneidensis MR-1的CT降低有关。当细胞以三甲胺-N-氧化物作为末端电子受体厌氧生长时,所有的甲萘醌突变体均表现出野生型水平的CT降低。我们得出的结论是,沙门氏菌MR-1产生了两种能够使CT脱卤的因素。在厌氧生长条件下产生的因子不是甲萘醌生物合成途径的产物。 [参考:18]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号